Melanoma to Vitiligo: The Melanocyte in Biology & Medicine
In-Person Event
Oct 17 - 22, 2018
Gleneden Beach, Oregon, USAOVERVIEW
Melanoma to Vitiligo: The Melanocyte in Biology & Medicine is organized by Montagna Symposium on the Biology of Skin and will be held from Oct 17 - 22, 2018 at Salishan Resort, Gleneden Beach, Oregon, United States of America.
The target audience for this medical event is Dermatologists, oncologists, rheumatologists, pathologists and other physicians treating patients with conditions that may be elucidated by presentation and discussion of current clinical and basic research relating to skin pigmentation. This CME Conference has been approved for a maximum of 17.00 AMA PRA Category 1 Credits.
The program will include state-of-the-art talks and the newest data on animal and human model systems of pigmentation defects; pigment cells in embryonic development; pigment stem cell biology; immunology and the microenvironment in melanoma and vitiligo; the genetics of pigmentation disorders; signal transduction in pigmented cells; and the chemistry and toxicology related to the biology and disorders of the melanocyte.
Ample opportunity will be available for young investigators, including graduate students and postdoctoral fellows, to present their recent advances in pigment cell biology, and to interact informally with peers, mentors, and leaders in the field.
Learning Objectives :
Through invited and accepted oral presentations, poster presentations, group debate, Q&A, and informal conversations, participants will interpret current research findings/approaches in melanocyte biology & chemistry and melanoma & vitiligo patient care and apply them, where appropriate, to their own research and practice. At the conclusion of the meeting, participants will be able to:
• evaluate the use of different animal models for understanding melanoma and vitiligo pathogenesis
• view human melanocyte biology at the scale of the “human model system
• review the role of stem cells and development in normal and disordered pigmentation
• associate immunological and microenvironmental processes with the development of melanoma and vitiligo
• recognize the relationship between genetics, early detection, and prevention of melanoma
• assess approaches to melanoma and vitiligo therapeutics that capitalize on cell signaling pathways; and
• examine the effects of the photochemistry and toxicology of pigment cells on human health. Participants will be able to identify and engage with colleagues in dermatology, oncology, and related fields who are working toward cutting-edge translational solutions to current problems in healthcare and who are open to collaboration and/or consultation. This meeting is designed promote conversations and ignite new ideas and new connections; desired changes in learner behavior include forming new collaborations, developing new research projects, designing new clinical trials, and applying new therapies in a clinical setting.
Additional details will be posted as soon as they are available.
The target audience for this medical event is Dermatologists, oncologists, rheumatologists, pathologists and other physicians treating patients with conditions that may be elucidated by presentation and discussion of current clinical and basic research relating to skin pigmentation. This CME Conference has been approved for a maximum of 17.00 AMA PRA Category 1 Credits.
The program will include state-of-the-art talks and the newest data on animal and human model systems of pigmentation defects; pigment cells in embryonic development; pigment stem cell biology; immunology and the microenvironment in melanoma and vitiligo; the genetics of pigmentation disorders; signal transduction in pigmented cells; and the chemistry and toxicology related to the biology and disorders of the melanocyte.
Ample opportunity will be available for young investigators, including graduate students and postdoctoral fellows, to present their recent advances in pigment cell biology, and to interact informally with peers, mentors, and leaders in the field.
Learning Objectives :
Through invited and accepted oral presentations, poster presentations, group debate, Q&A, and informal conversations, participants will interpret current research findings/approaches in melanocyte biology & chemistry and melanoma & vitiligo patient care and apply them, where appropriate, to their own research and practice. At the conclusion of the meeting, participants will be able to:
• evaluate the use of different animal models for understanding melanoma and vitiligo pathogenesis
• view human melanocyte biology at the scale of the “human model system
• review the role of stem cells and development in normal and disordered pigmentation
• associate immunological and microenvironmental processes with the development of melanoma and vitiligo
• recognize the relationship between genetics, early detection, and prevention of melanoma
• assess approaches to melanoma and vitiligo therapeutics that capitalize on cell signaling pathways; and
• examine the effects of the photochemistry and toxicology of pigment cells on human health. Participants will be able to identify and engage with colleagues in dermatology, oncology, and related fields who are working toward cutting-edge translational solutions to current problems in healthcare and who are open to collaboration and/or consultation. This meeting is designed promote conversations and ignite new ideas and new connections; desired changes in learner behavior include forming new collaborations, developing new research projects, designing new clinical trials, and applying new therapies in a clinical setting.
Additional details will be posted as soon as they are available.
KEY DATES
17 Oct, 2018
Event Start Date
22 Oct, 2018
Event End Date
SPECIALITIES
Immunology and MicrobiologyDermatologyOncologySUGGESTED HOTELS
CONFERENCE VENUE
Salishan ResortRELATED CONFERENCES & LIVE WEBINARS
Quick Links